ASX:MPH

Mediland Pharm Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume4,000 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive MPH News and Ratings via Email

Sign-up to receive the latest news and ratings for Mediland Pharm and its competitors with MarketBeat's FREE daily newsletter.


About Mediland Pharm

Mediland Pharm Limited, together with subsidiaries, engages in the retail sale of health, beauty, and wellness products in Australia and New Zealand. The company's stores also offers luxury products, such as opal and pink diamond jewelry pieces, souvenirs and gifts, luxurious bedding and rugs. It operates through one direct store in Australia; one store in Auckland, New Zealand; six franchise shops in China; three WeChat accounts; and four e-commerce platforms. The company was founded in 2002 and is headquartered in Sydney, Australia.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.56 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Mediland Pharm (ASX:MPH) Frequently Asked Questions

What stocks does MarketBeat like better than Mediland Pharm?

Wall Street analysts have given Mediland Pharm a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Mediland Pharm wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Mediland Pharm's key executives?

Mediland Pharm's management team includes the following people:
  • Mr. Yeshween Mudaliar, MD & Director
  • Ms. Jessie Tao, Chief Financial Officer
  • Mr. Jhon Shen, Exec. Director
  • Ms. Indira Naidu, Company Sec.

Who are some of Mediland Pharm's key competitors?

What is Mediland Pharm's stock symbol?

Mediland Pharm trades on the ASX under the ticker symbol "MPH."

How much money does Mediland Pharm make?

Mediland Pharm has a market capitalization of $0.00 and generates $4.63 million in revenue each year.

What is Mediland Pharm's official website?

The official website for Mediland Pharm is www.medilandpharm.com.au.

How can I contact Mediland Pharm?

The company can be reached via phone at 61 2 9261 1594.


This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.